

Biography
She graduated from Rutgers University with Phi Beta Kappa distinction and a degree in psychology. She attended Rutgers New Jersey Medical School in Newark, NJ, where she led multiple community service and medical education activities and was elected to the Alpha Omega Alpha and Gold Humanism Honor Societies. She moved to the Bay Area to pursue neurology residency at Stanford, where she later served as chief resident. She then completed two years of fellowship in EMG/Clinical Neurophysiology and Neuromuscular Medicine and research training at Forbes Norris MDA/ALS Research Center.
Dr. Sakamuri's passion is neuromuscular medicine, with a focus on peripheral nerve traumas and disorders. She is Co-Director of the Center for Peripheral Nerve Surgery along with neurosurgeon Dr. Thomas J. Wilson. She performs advanced evaluations of peripheral nerve conditions by integrating nerve and muscle ultrasound and neurophysiologic testing (EMG/NCS) at the bedside. She has advanced training in nerve and muscle ultrasound, and sits on the Neuromuscular Ultrasound Committee of the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM).
She is board-certified in Neurology and in Neuromuscular disorders by the American Board of Psychiatry and Neurology (ABPN). She is certified in EMG/NCS by the American Board of Electrodiagnostic Medicine (ABEM), and holds a Certificate of Added Qualification in Neuromuscular Ultrasound.
Dr. Sakamuri's other passion is graduate medical education. She is the Program Director of the Stanford Neuromuscular Medicine Fellowship and Associate Director of the Clinical Neurophysiology/EMG Fellowship, with a total of five ACGME-accredited positions filled by extremely bright and talented fellows. She supervises a weekly neurology resident continuity clinic and enjoys teaching medical students and neurology and physiatry residents and fellows. She been awarded the Lysia S. Forno Award for outstanding contributions to resident teaching.
Professional Summary
Education & Certifications
- Residency: Stanford University Dept of Neurology (2012) CA
- Board Certification: American Board of Electrodiagnostic Medicine, Neuromuscular Ultrasound Certificate of Added Qualification (2019)
- Fellowship: Stanford University Neuromuscular Medicine Fellowship (2014) CA
-
- Fellowship: Stanford University Clinical Neurophysiology Fellowship (2013) CA
- Internship: Rutgers New Jersey Medical School UMDNJ Internal Medicine Residency (2009) NJ
- Medical Education: Rutgers New Jersey Medical School Office of the Registrar (2008) NJ
- Board Certified, Electrodiagnostic Medicine, American Board of Electrodiagnostic Medicine (2015)
- Board Certified, Neuromuscular Medicine, American Board of Psychiatry and Neurology (2014)
- Board Certified, Neurology, American Board of Psychiatry and Neurology (2012)
- Research Fellowship, Respiratory dysfunction in ALS, California Pacific Medical Center, Forbes Norris MDA/ALS Research Center (2014)
- Fellowship, Neuromuscular Medicine, Stanford University School of Medicine (2014)
- Fellowship, EMG/Clinical Neurophysiology, Stanford University School of Medicine (2013)
- Residency, Neurology, Stanford Hospital & Clinics (2012)
- Internship, Internal Medicine, New Jersey Medical School (2009)
- Medical Education, New Jersey Medical School (2008)
Honors & Awards
- American Academy of Neurology Medical Student Prize, American Academy of Neurology (2008)
- American Academy of Neurology Resident Scholarship, American Academy of Neurology (2012)
- Member, Alpha Omega Alpha Medical Honor Society (2008)
-
- Member, Arnold P. Gold Humanism Honor Society (2008)
- Member, Phi Beta Kappa (2004)
- Neurology Medical Student Clerkship Teaching Award, Stanford Department of Neurology (2010)
- Neurology Medical Student Clerkship Teaching Award, Stanford Department of Neurology (2012)
- Nomination for Golden Apple Teaching Award, New Jersey Medical School (2009)
Memberships
- Member, Fellowship Committee, American Association of Neuromuscular and Electrodiagnostic Medicine (2021 - Present)
- Member, Ultrasound Committee, American Association of Neuromuscular and Electrodiagnostic Medicine (2016 - 2021)
- Member, GME Committee, American Association of Neuromuscular and Electrodiagnostic Medicine (2017 - 2021)
-
- Member, American Association of Neuromuscular and Electrodiagnostic Medicine (2012 - Present)
- Member, American Academy of Neurology Neuromuscular Section (2012 - Present)
- Member, American Academy of Neurology (2009 - Present)
Administrative Appointments
- Associate Director, Clinical Neurophysiology/EMG Fellowship, Stanford University School of Medicine (2015 - Present)
- Associate Director, Neuromuscular Medicine Fellowship, Stanford University School of Medicine (2015 - 2019)
- Co-Director, Center for Peripheral Nerve Surgery, Stanford University Departments of Neurosurgery and Neurology (2017 - Present)
-
- Director, Neuromuscular Medicine Fellowship, Stanford University School of Medicine (2019 - Present)
Publications
-
Congenital muscular dystrophy and generalized epilepsy caused by GMPPB mutations.
Raphael, A. R., Couthouis, J., Sakamuri, S., Siskind, C., Vogel, H., Day, J. W., & Gitler, A. D. (2014). Congenital muscular dystrophy and generalized epilepsy caused by GMPPB mutations. Brain Research, 1575, 66–71. -
Perioperative ischemic optic neuropathy (POION).
Bennett, H. L., Origlieri, C., & Sakamuri, S. (2005). Perioperative ischemic optic neuropathy (POION). Spine, 30(23), 2706-? -
Phrenic nerve conduction studies as a biomarker of respiratory insufficiency in amyotrophic lateral sclerosis
Jenkins, J. A. L., Sakamuri, S., Katz, J. S., Forshew, D. A., Guion, L., Moore, D., & Miller, R. G. (2016). Phrenic nerve conduction studies as a biomarker of respiratory insufficiency in amyotrophic lateral sclerosis. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 17(3-4), 213–20. -
-
Increased EEG Theta Spectral Power in Sleep in Myotonic Dystrophy Type 1.
Cheung, J., Ruoff, C., Moore, H., Hagerman, K. A., Perez, J., Sakamuri, S., … Sampson, J. (2018). Increased EEG Theta Spectral Power in Sleep in Myotonic Dystrophy Type 1. Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine, 14(2), 229–35. -
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
Howard, J. F., Utsugisawa, K., Benatar, M., Murai, H., Barohn, R. J., Illa, I., … Mantegazza, R. (2017). Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. LANCET NEUROLOGY, 16(12), 976–86. -
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
Mercuri, E., Darras, B. T., Chiriboga, C. A., Day, J. W., Campbell, C., Connolly, A. M., … Finkel, R. S. (2018). Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy. NEW ENGLAND JOURNAL OF MEDICINE, 378(7), 625–35. -
An Update on the Management of Adult Traumatic Nerve Injuries-Replacing Old Paradigms: A Review.
Smith, B. W., Sakamuri, S., Spain, D. A., Joseph, J. R., Yang, L. J.-S., & Wilson, T. J. (2018). An Update on the Management of Adult Traumatic Nerve Injuries-Replacing Old Paradigms: A Review. The Journal of Trauma and Acute Care Surgery. -
Sleep and Neuromuscular Disease
Sakamuri, S., & Day, J. W. (2017). Sleep and Neuromuscular Disease. Sleep and Neurologic Disease (pp. 183–200). Elsevier. -
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.
Muppidi, S., Utsugisawa, K., Benatar, M., Murai, H., Barohn, R. J., Illa, I., … Howard, J. F. (2019). Long-term safety and efficacy of eculizumab in generalized myasthenia gravis. Muscle & Nerve. -
An update on the management of adult traumatic nerve injuries-replacing old paradigms: A review
Smith, B. W., Sakamuri, S., Spain, D. A., Joseph, J. R., Yang, L. J.-S., & Wilson, T. J. (2019). An update on the management of adult traumatic nerve injuries-replacing old paradigms: A review. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 86(2), 299–306. -
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis
Muppidi, S., Utsugisawa, K., Benatar, M., Murai, H., Barohn, R. J., Illa, I., … Gandolfo, R. (2019). Long-term safety and efficacy of eculizumab in generalized myasthenia gravis. MUSCLE & NERVE, 60(1), 14–24. -
Guidelines for neuromuscular ultrasound training.
Tawfik, E. A., Cartwright, M. S., Grimm, A., Boon, A. J., Kerasnoudis, A., Preston, D. C., … Walker, F. O. (2019). Guidelines for neuromuscular ultrasound training. Muscle & Nerve. -
Imaging of Damaged Nerves.
Purger, D. A., Sakamuri, S., Hug, N. F., Biswal, S., & Wilson, T. J. (2020). Imaging of Damaged Nerves. Clinics in Plastic Surgery, 47(2), 245–59. -
Allograft Nerve Repair Reduces Postoperative Neuropathic Pain Following Nerve Biopsy.
Sakamuri, S., & Wilson, T. J. (2020). Allograft Nerve Repair Reduces Postoperative Neuropathic Pain Following Nerve Biopsy. Neurosurgery. -
Increased EEG theta spectral power in polysomnography of myotonic dystrophy type 1 compared to matched controls.
Ruoff, C., Cheung, J., Perez, J., Sakamuri, S., Mignot, E., Day, J., & Sampson, J. (2017). Increased EEG theta spectral power in polysomnography of myotonic dystrophy type 1 compared to matched controls. NEUROLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension.
Mantegazza, R., Wolfe, G. I., Muppidi, S., Wiendl, H., Fujita, K. P., O'Brien, F. L., … Howard, J. F. (2020). Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension. Neurology. -
Neuromuscular ultrasound competency assessment: Consensus-Based survey.
Tawfik, E. A., Cartwright, M. S., Grimm, A., Boon, A. J., Kerasnoudis, A., Preston, D. C., … Walker, F. O. (2020). Neuromuscular ultrasound competency assessment: Consensus-Based survey. Muscle & Nerve. -
Assessment of variability in motor grading and patient-reported outcome reporting: a multi-specialty, multi-national survey.
Smith, B. W., Sakamuri, S., Flavin, K. E., Jensen, M., Purger, D. A., Yang, L. J.-S., … Wilson, T. J. (2021). Assessment of variability in motor grading and patient-reported outcome reporting: a multi-specialty, multi-national survey. Acta Neurochirurgica. -
Small nerve fiber involvement in chilblain lupus erythematosus (late breaking abstract)
Sakamuri, S., Muppidi, S., & Leung, K. (2021). Small nerve fiber involvement in chilblain lupus erythematosus (late breaking abstract). JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. WILEY. -
Research reporting in cubital tunnel syndrome studies: an analysis of the literature.
Hug, N. F., Smith, B. W., Sakamuri, S., Jensen, M., Purger, D. A., Spinner, R. J., & Wilson, T. J. (1800). Research reporting in cubital tunnel syndrome studies: an analysis of the literature. Acta Neurochirurgica. -
The neuromuscular fellowship portal and match.
London, Z. N., Gable, K. L., Govindarajan, R., Guidon, A. C., Gwathmey, K. G., Hehir, M. K., … Baer, M. (2022). The neuromuscular fellowship portal and match. Muscle & Nerve. -
Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trial.
Kohler, W., Engelen, M., Eichler, F., Lachmann, R., Fatemi, A., Sampson, J., … Mochel, F. (2023). Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trial. The Lancet. Neurology, 22(2), 127–136. -
Physician Perceptions of Performance Feedback and Impact on Personal Well-Being: A Qualitative Exploration of Patient Satisfaction Feedback in Neurology.
Vilendrer, S., Levoy, E., Miller-Kuhlmann, R., Amano, A., Brown-Johnson, C., De Borba, L., … Gold, C. A. (2022). Physician Perceptions of Performance Feedback and Impact on Personal Well-Being: A Qualitative Exploration of Patient Satisfaction Feedback in Neurology. Joint Commission Journal on Quality and Patient Safety. -
Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trial
Koehler, W., Engelen, M., Eichler, F., Lachmann, R., Fatemi, A., Sampson, J., … Adv Study Grp. (2023). Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trial. LANCET NEUROLOGY, 22(2), 127–136. -
Neuromuscular ultrasound standardized scanning techniques and protocols: Expert panel recommendations.
Tawfik, E. A., Cartwright, M. S., van Alfen, N., Axer, H., Boon, A. J., Crump, N., … Walker, F. O. (2023). Neuromuscular ultrasound standardized scanning techniques and protocols: Expert panel recommendations. Muscle & Nerve. -
Surgical Release of Ulnar and Median Nerves in CMT1A: Prevention and Treatment of a Second Hit
McKeen, W., Katyal, N., Sakamuri, S., Wilson, T., & Greene, M. (2023). Surgical Release of Ulnar and Median Nerves in CMT1A: Prevention and Treatment of a Second Hit. NEUROLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
The Neuromuscular Portal and Match: Working Toward a More Fair, Equitable, and Transparent Process.
Laughlin, R. S., Adkins, S., Baer, M., Dehbashi, S., Gable, K., Govindarajan, R., … London, Z. (2023). The Neuromuscular Portal and Match: Working Toward a More Fair, Equitable, and Transparent Process. Neurology. Education, 2(3), e200086.
-
Increased EEG Theta Spectral Power in Sleep in Myotonic Dystrophy Type 1.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1
- A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)
- Embodied Virtual Reality Therapy for Functional Neurological Symptom/ Conversion Disorder
- Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Myotubular Myopathy (MTM)
- Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
- Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Practice Locations
Neuromuscular Program at the Neuroscience Health Center Palo Alto, CA
Palo Alto, CANeuromuscular Program at the Neuroscience Health Center
213 Quarry Rd
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereStanford Neuroscience Health Center Palo Alto, CA
Palo Alto, CAStanford Neuroscience Health Center
213 Quarry Rd
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereNeurogenetic Cancer Palo Alto, CA
Palo Alto, CANeurogenetic Cancer
213 Quarry Rd
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HerePeripheral Nerve Surgery Program Palo Alto, CA
Palo Alto, CAPeripheral Nerve Surgery Program
213 Quarry Rd
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(107 reviews)
View More Patient Reviews
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records